返回排名列表

Huron Consulting Group Inc. (HURN)

合理估值
IndustrialsConsulting ServicesUnited States

基本面

70

价格

$169.14

市值

$2.50B

第一部分 · 这家公司值多少

概览

Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users

Guidehouse Inc.Not tracked

Guidehouse, which absorbed Navigant's healthcare practice, sells the same hospital and health-system performance improvement, revenue cycle and research administration advisory that Huron's Healthcare and Education segments live on.

The Chartis Group, LLCNot tracked

Chartis is a pure-play healthcare advisory firm bidding for the same strategy, clinical and operational transformation projects at US hospitals and academic medical centers that make up Huron's largest segment.

FTI Consulting, Inc.FCN

FTI's corporate finance and business transformation practice competes with Huron for performance improvement, restructuring and financial advisory mandates from the same US corporate and healthcare clients.

Accenture plcACN

Accenture competes head-on with Huron's Digital capability, implementing the same Oracle, Workday and Salesforce platforms for health systems and universities, with far greater scale.

Deloitte Touche Tohmatsu LimitedNot tracked

Deloitte's healthcare and higher-education consulting practices pursue the same hospital and university transformation budgets, and Huron's 10-K names the consulting arms of the major accounting firms among its competitors.

ICF International, Inc.ICFI

ICF sells advisory and technology implementation services to public-sector, health and research institutions, overlapping with Huron's Education and Commercial segments.

资产负债表与流动性

营收

$1.75B

最近12个月(截至2026/3/31)

净利润

$104M

最近12个月(截至2026/3/31)

自由现金流

$183M

股东权益合计

$529M

负债合计

$998M

流动比率

2.22

利息覆盖率

-

债务/EBITDA

4.21

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

一般情形合理估值

公允价值

$183.81

当前价格

$169.14

安全边际

+8.0%

公允价值区间

$119.48 - $248.15

所用估值方法之间的离散区间,并非经过统计校准的置信区间。

估算方法

分析师目标价:$190.75
现金流折现法(DCF):$304.31
市盈率法(P/E):$103.37
格雷厄姆成长公式:$108.10
盈利能力价值(EPV):$111.58
合理市净率(P/B):$128.72
股息折现模型(戈登模型):数据不足,无法计算
P/FFO(运营资金):$135.67
周期中段收益:$199.34
市销率法(P/S):$314.12
分析师共识:强力买入 (10B / 1H / 0S)
最近财报超预期:+10.94%

估值指标

市盈率(P/E)

26.81

ROE

19.9%

市净率(P/B)

6.40

P/FCF

20.54

毛利率

-

ROIC

10.6%

盈利能力雷达图

价值创造(经济护城河)

ROIC

10.6%

WACC

5.9%

ROIC − WACC

+4.7 pp

ROIC 超过资本成本:公司正在为股东创造价值。

基本面分析标准

通过(18)

  • EPS shows upward trend
  • EPS CAGR 15.16%
  • Price CAGR 12.19%
  • ROIC 10.6%
  • P/FCF 20.54
  • Debt/Equity ratio
  • Operating Margin 10.4%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 25.5%
  • Revenue Growth 5Y 14.3%
  • Analyst Consensus 91% Buy
  • Earnings Surprise avg 9.0%
  • Earnings Quality (OCF/NI) 1.33
  • Share Dilution -3.3%

未通过(6)

  • P/B Ratio 6.40
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Net Margin Trend 5.9% vs 7.9%
  • Piotroski F-Score 4/9

不可用(4)

  • Gross Margin NaN%
  • Dividend Payout NaN%
  • Interest Coverage
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-评分

4/9

信号混杂:部分领域需关注

score
criteria

盈利质量

1.33

高质量:盈利有现金流支撑

股权稀释

-3.3%

正在回购股份,对股东友好

机构持股

公司治理

管理团队

姓名职位年龄
Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A.President, CEO & Director64
Mr. John D. Kelly CPA, M.S.Executive VP, CFO & Treasurer48
Mr. J. Ronald DailExecutive VP & COO54
Ms. Hope E. Katz J.D.Executive VP, General Counsel & Corporate Secretary-
Mr. Kyle D. FeatherstoneChief Accounting Officer & Corporate VP44
Mr. Sean FreeburgerChief Information Officer-
Allie BovisDirector of Communications-
Elizabeth EntingheCorporate Vice President of Corporate Development-
Sarah McHughCorporate VP & Chief Marketing Officer-
Ms. Kristen BrunerChief Human Resources Officer & Corporate VP-

审计风险

1

董事会风险

3

薪酬风险

3

股东权利风险

6

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。

文件

  • 年度报告(10-K)

    对公司业务、财务业绩和风险的年度概述。

    提交日期:2026-02-24

    查看文件
  • 季度报告(10-Q)

    最近三个月财务表现的最新情况。

    提交日期:2026-07-28

    查看文件
  • 临时报告(8-K)

    关于重大事件(如管理层变动或重要公告)的通知。

    提交日期:2026-07-28

    查看文件

via SEC EDGAR

损益历史

via SEC EDGAR

Latest News

Recent headlines for HURN, sourced from Markets Gazette.

  • 5/5/2026NEUTRAL
    Huron Consulting Gr Q1 2026 Earnings Call Transcript

    Huron Consulting Group Inc. (HURN) released its Q1 2026 Earnings Call Transcript on May 5, 2026. The transcript provides detailed insights into the company's financial performance, strategic initiatives, and outlook for the upcoming quarters. While specific financial figures and forward-looking statements are discussed, the transcript itself is an informational document rather than a direct announcement of new performance data or significant strategic shifts that would immediately impact the stock price. Investors can use this transcript to gain a deeper understanding of management's perspective and the underlying business drivers.

via Markets Gazette